Kent Imaging Partners with New Horizon Medical Solutions
Kent Imaging is proud to announce a new partnership with New Horizon Medical Solutions for distribution of the Snapshot Suite, SnapshotNIR and SnapshotGLO.
"This partnership positions us for a breakthrough year in 2026," said New Horizon Medical Solutions CEO Will Hall. "With access to best-in-class diagnostic tools, clinicians will be empowered to use our products more effectively and document outcomes with greater accuracy - ultimately improving patient care across the country."
SnapshotNIR is a portable, non-invasive device that uses near-infrared spectroscopy to measure oxygenated and deoxygenated hemoglobin in the microvasculature. It displays real-time visual maps and objective values of oxyhemoglobin, deoxyhemoglobin, total hemoglobin, and tissue oxygen saturation (StO2), offering clinicians unprecedented insight into tissue viability, oxygenation status, and wound healing progression.
SnapshotGLO is a handheld, portable bacteria assessment device that measures wound bioburden, monitors wound healing and assists clinicians’ decision-making for first-line treatments. Using safe, ultraviolet (UV) light, SnapshotGLO provides users with a visual map of elevated bacterial loads in a wound. The device can highlight areas of bacterial loads over 10(4) CFU/g*, aiding clinicians in providing timely, targeted interventions.
Read the press release to learn more about this exciting collaboration.
*colony-forming units per gram of tissue
About New Horizon Medical Solutions
New Horizon Medical Solutions (NHMS), a leader in advanced wound care technologies, develops and delivers biologically derived human placental allograft products designed to meet the highest standards of safety and performance. New Horizon's portfolio spans amniotic membranes, placental tissues, and skin grafts for chronic wounds, surgical reconstruction, burns, and orthopedic procedures. Through evidence-based design and precision manufacturing, NHMS delivers solutions that align with real-world clinical practices and improve patient outcomes. www.nhmedical.com
About Kent Imaging
Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in advanced diagnostic imaging, developing, manufacturing, and marketing medical technology that supports real-time decision-making in wound care, vascular, and surgical subspecialties. Through patented imaging technologies, Kent continues to provide innovative solutions that aid healthcare systems nationally and internationally.
The Snapshot product suite now includes two powerful imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device initially cleared by the FDA and Health Canada in 2017 and CE-marked in 2025; and SnapshotGLO, a bacterial autofluorescence imaging device that received FDA 510(k) clearance in 2025. SnapshotNIR is supported by clinical evidence demonstrating its role in enhancing clinical decision-making, while SnapshotGLO provides real-time insight into wound bioburden presence and distribution. Together, the Snapshot product family strengthens clinicians’ ability to detect, direct, and protect—promoting treatment consistency, supporting improved workflow, and contributing to better patient care worldwide.